Max Pillong

Max Pillong

Auto-generated profile, based on publicly available information

Max Pillong

Department of Chemistry and Applied Bioscience , ETH Zürich , CH-8093 Zürich , Switzerland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
BGBasri Gülbakan
Basri Gülbakan
KBKonstantin Barylyuk
Konstantin Barylyuk
PSPetra Schneider
Petra Schneider
MPMax Pillong
Max Pillong
GSGisbert Schneider
Gisbert Schneider
RZRenato Zenobi
Renato Zenobi

6 June 2013 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
CKChristian P. Koch
Christian P. Koch
APAnna M. Perna
Anna M. Perna
MPMax Pillong
Max Pillong
NTNickolay K. Todoroff
Nickolay K. Todoroff
PWPaul Wrede
Paul Wrede
GSGisbert Schneider
Gisbert Schneider
Designed peptides that bind to major histocompatibility protein I (MHC-I) allomorphs bear the promise of representing epitopes that stimulate a desired immune response. A rigorous bioinformatical exploration of sequence patterns hidden in peptides that bind to the mouse MHC-I allomorph H-2Kb is presented. We exemplify and validate these motif findings by systematically dissecting the epitope SIINFEKL and analyzing the resulting fragments for their binding potential to H-2Kb in a thermal denaturation assay. The results demonstrate that only fragments exclusively retaining the carboxy- or amino-terminus of the reference peptide exhibit significant binding potential, with the N-terminal pentapeptide SIINF as shortest ligand. This study demonstrates that sophisticated machine-learning algorithms excel at extracting fine-grained patterns from peptide sequence data and predicting MHC-I binding peptides, thereby considerably extending existing linear prediction models and providing a fresh view on the computer-based molecular design of future synthetic vaccines. The server for prediction is available at http://modlab-cadd.ethz.ch (SLiDER tool, MHC-I version 2012). Future success in vaccine development will critically depend on identifying potent epitopes with reduced side effects. Among such candidate molecules, immunogenic peptides binding to major histocompatibility protein I (MHC-I) represent a preferred class of biomolecules for vaccine design. Computational models assist in the selection of the best candidate peptides by providing a mathematical rationale for antigen recognition by MHC-I. Here we present a machine-learning model that was trained on recognizing features of known MHC-I binding and non-binding peptide sequences with sustained accuracy. We were able to biochemically validate the computational predictions in a direct binding assay measuring complex formation between synthesized candidate peptides and MHC-I. Strong correspondence between the predictions and the experimentally determined binding potential corroborate the machine-learning model as viable for future antigen design. Thus, our study provides a concept for rapidly finding innovative MHC-I binding peptides with limited experimental effort.

11 August 2017 in Small
Verified
Journal Article
Closed access
PDF file
MPMax Pillong
Max Pillong
JHJan A. Hiss
Jan A. Hiss
PSPetra Schneider
Petra Schneider
YLYen‐Chu Lin
Yen‐Chu Lin
GPGernot Posselt
Gernot Posselt
GSGisbert Schneider
Gisbert Schneider

30 June 2014 in Chemical Science
Verified
Journal Article
Closed access
PDF file
APAnna Maria Perna
Anna Maria Perna
FRFelix Reisen
Felix Reisen
TSThomas P. Schmidt
Thomas P. Schmidt
TGTim Geppert
Tim Geppert
MPMax Pillong
Max Pillong
GSGisbert Schneider
Gisbert Schneider
Structure-based virtual screening retrieves an inhibitor of Helicobacter pylori infection that blocks pathogen invasion across the epithelial barrier.

31 May 2017 in CrystEngComm
Verified
Journal Article
Closed access
PDF file
MPMax Pillong
Max Pillong
CMCorinne Marx
Corinne Marx
PPPhilippe Piechon
Philippe Piechon
JWJerome G. P. Wicker
Jerome G. P. Wicker
RCRichard I. Cooper
Richard I. Cooper
TWTrixie Wagner
Trixie Wagner
A publicly available crystallisation database for clusters of highly similar compounds is used to build machine learning models.

1 December 2015 in Pharmacological Research
Verified
Journal Article
Closed access
AHArne Henkel
Arne Henkel
LTLars Tausch
Lars Tausch
MPMax Pillong
Max Pillong
JJJohann Jauch
Johann Jauch
MKMichael Karas
Michael Karas
OWOliver Werz
Oliver Werz